Alyeska Investment Group »

Lisata Therapeutics shares owned by Alyeska Investment Group

Quarter-by-quarter ownership of Lisata Therapeutics (LSTA) shares owned by Alyeska Investment Group from 13F filings

Historical chart of Alyeska Investment Group investment in Lisata Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lisata Therapeutics held by Alyeska Investment Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lisata Therapeutics by Alyeska Investment Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $74k 27k 2.73

More positions owned by Alyeska Investment Group

Meta Platforms Cl A (META)
Aercap Holdings Nv SHS (AER)
Take-Two Interactive Software (TTWO)
Epam Systems (EPAM)
Dollar General (DG)
Paycom Software (PAYC)
Twilio Cl A (TWLO)
Burlington Stores (BURL)
Lauder Estee Cos Cl A (EL)
Adobe Systems Incorporated (ADBE)
Oracle Corporation (ORCL)
Autodesk (ADSK)
Xylem (XYL)
Ulta Salon, Cosmetics & Fragrance (ULTA)
Amazon (AMZN)

View all positions for Alyeska Investment Group

Top funds holding Lisata Therapeutics

BML Capital Management
Vanguard Group
Alyeska Investment Group
Citadel Advisors
Cook Wealth Management Group
Susquehanna International
HighTower Advisors
Bank of America Corporation
Founders Capital Management
UBS Group
Wells Fargo & Company
Royal Bank of Canada
Jpmorgan Chase & Co
Steward Partners Investment Advisory
Barclays

View all funds holding Lisata Therapeutics